Phone: +49 (0)345 27996330
Fax: +49 (0)345 27996332
Scil Proteins is an integrated, medium-sized biopharmaceutical company. Its key value driver is the proprietary Affilin® protein drug discovery platform. The company develops Affilin® based therapeutics in applications where antibodies have clear limitations. Scil Proteins focuses on early Affilin® product developments in oncology whereas Affilin® drug discovery partnerships covers various indications.
Additionally, Scil Proteins offers contract development and contract manufacturing for recombinant proteins to international pharma and biotech companies. The longstanding, scientific profound microbial protein manufacturing expertise strongly contributes to the success of our customer projects. We provide cell line development, process development and API supply for preclinic, clinic and market.